135 related articles for article (PubMed ID: 6183567)
1. Hepatic artery infusion with 5-fluorouracil and mitomycin-C in metastatic colorectal carcinoma phase II study.
Theodors A; Bukowski RM; Lavery I; Hewlett JS; Livingston RB; Buonocore E
Med Pediatr Oncol; 1982; 10(5):463-70. PubMed ID: 6183567
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
Patt YZ; Mavligit GM; Chuang VP; Wallace S; Johnston S; Benjamin RS; Valdivieso M; Hersh EM
Cancer; 1980 Jul; 46(2):261-5. PubMed ID: 6446376
[TBL] [Abstract][Full Text] [Related]
3. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
[TBL] [Abstract][Full Text] [Related]
4. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
5. Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma.
Smith GW; Bukowski RM; Hewlett JS; Groppe CW
Cancer; 1984 Oct; 54(8):1513-6. PubMed ID: 6089991
[TBL] [Abstract][Full Text] [Related]
6. Hepatic artery infusion chemotherapy for colorectal metastases: a personal experience.
Donegan WL
J Surg Oncol; 1985 Nov; 30(3):177-83. PubMed ID: 2934584
[TBL] [Abstract][Full Text] [Related]
7. Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy.
Cohen AM; Schaeffer N; Higgins J
Cancer; 1986 Mar; 57(6):1115-7. PubMed ID: 3080221
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.
Wils J; Schlangen J; Naus A
Cancer Chemother Pharmacol; 1984; 13(3):215-7. PubMed ID: 6548420
[TBL] [Abstract][Full Text] [Related]
10. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
Lorenz M; Müller HH
J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
[TBL] [Abstract][Full Text] [Related]
11. Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: a phase II trial using intermittent percutaneous hepatic arterial access.
Copur MS; Capadano M; Lynch J; Goertzen T; McCowan T; Brand R; Tempero M
J Clin Oncol; 2001 May; 19(9):2404-12. PubMed ID: 11331319
[TBL] [Abstract][Full Text] [Related]
12. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival.
Link KH; Sunelaitis E; Kornmann M; Schatz M; Gansauge F; Leder G; Formentini A; Staib L; Pillasch J; Beger HG
Cancer; 2001 Dec; 92(11):2746-53. PubMed ID: 11753947
[TBL] [Abstract][Full Text] [Related]
13. 5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases.
Pernot S; Velut G; Kourie RH; Amouyal G; Sapoval M; Pointet AL; Landi B; Zaimi Y; Lepère C; Pellerin O; Taieb J
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):255-260. PubMed ID: 29233520
[TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
[TBL] [Abstract][Full Text] [Related]
15. Regional chemotherapy of colorectal cancer metastatic to the liver.
Niederhuber JE; Ensminger W; Gyves J; Thrall J; Walker S; Cozzi E
Cancer; 1984 Mar; 53(6):1336-43. PubMed ID: 6229326
[TBL] [Abstract][Full Text] [Related]
16. Phase II evaluation of sequential hepatic artery infusion of 5-fluorouracil and hepatic irradiation in metastatic colorectal carcinoma.
Miller RL; Bukowski RM; Andresen S; Gahbauer R
J Surg Oncol; 1988 Jan; 37(1):1-4. PubMed ID: 3336213
[TBL] [Abstract][Full Text] [Related]
17. [Complications of intra-arterial infusion chemotherapy in patients with colorectal cancer with liver metastasis, with special reference to IA-5-FU induced sclerosing cholangitis].
Sawada T; Hojo K; Moriya Y
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3087-91. PubMed ID: 2506836
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of intra-arterial fluorouracil and mitomycin-C for liver metastases of colorectal cancer.
Metzger U; Weder W; Röthlin M; Largiadèr F
Recent Results Cancer Res; 1991; 121():198-204. PubMed ID: 1907015
[TBL] [Abstract][Full Text] [Related]
19. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
20. [Intra-arterial chemotherapy of colorectal liver metastases with 5-fluorouracil (5-FU) and mitomycin C (MMC)].
Weder W; Roethlin M; Metzger U; Largiadèr F
Helv Chir Acta; 1987 Dec; 54(4):383-6. PubMed ID: 3128495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
